Sheehan John D

Avg. Two Year Performance

(13%) Avg. Purchase Return
(6%) Compound
(5%) Avg. Sale Return
(2%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(13%)(12%)(8%)(10%)(13%)
Purchase Success Rate20 of 3515 of 3511 of 356 of 352 of 35
Average Sale Return(4%)(11%)(8%)(9%)(5%)
Sale Success Rate1 of 62 of 61 of 62 of 62 of 6

Mylan, Inc.

Drugs » Drugs - Generic

EVP and CFO:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Delphi Corp.

Other » Other

VP Chief Restructuring Officer:

Holdings: 60 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Mylan N.V.

Drugs » Drugs - Generic

EVP and CFO:

Holdings: 193.73K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Terex Corp.

Industrial » Farm & Construction Machinery

:

Holdings: 149.33K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--